Read + Share
Amedeo Smart
Independent Medical Education
Lehto J, Sucksdorff M, Nylund M, Raitanen R, et al. PET-measurable innate immune cell activation reduction in chronic active lesions in PPMS brain after rituximab treatment: a case report. J Neurol 2023;270:2329-2332.PMID: 36576574
Email
LinkedIn
Facebook
Twitter
Privacy Policy